Results for: Bowel Cancer

In May 2019, 31-year-old Chloe was diagnosed with rectal cancer. Despite undergoing successful surgery and chemotherapy, she faced further challenges when a secondary cancer was discovered in her lung. Through it all, her determination and support from her family and healthcare team never wavered. After going through multiple IVF cycles and overcoming setbacks, Chloe’s dream of having a family came true with the birth of her son, Charlie, in February 2023. Her story highlights the importance of early detection, the resilience of the human spirit, and the power of hope in the face of adversity.

The family of Dame Deborah James is urging all UK political parties to commit to a long-term cancer strategy to give more cancer patients a better chance of survival. Dame Deborah died in June 2022 at the age of 40, five years after she was diagnosed with bowel cancer. She used her diagnosis to raise awareness of the disease and set up the Bowelbabe Fund for Cancer Research UK. In an open letter, Dame Deborah’s family said they are joining Cancer Research UK in its Longer, Better Lives manifesto during Bowel Cancer Awareness Month. The manifesto calls for the Government to publish a long-term cancer strategy within one year of the general election, to “drive earlier diagnosis and reduce inequalities in access to treatment and care”.

The family of the late Dame Deborah James, who passed away from bowel cancer in 2022, has issued a plea to political parties in the United Kingdom to prioritize a long-term cancer strategy. In a heartfelt letter published in The Sun, James’ family expressed their belief that early diagnosis and reduced inequalities in access to treatment are crucial for giving cancer patients more time with their loved ones. They emphasized the importance of increasing the NHS cancer workforce and investing in vital diagnosis equipment to ensure timely and accurate testing for all those in need.

Regular aspirin use has been found to enhance the body’s immune response against bowel cancer cells, potentially explaining its protective effects. Researchers discovered that aspirin increases levels of a protein on immune cells, allowing them to better detect and destroy cancer cells. The study also supports aspirin’s ability to reduce the spread of bowel cancer, particularly in rectal cancer where it boosts immune surveillance in healthy tissue.